Willkie advised IK Investment Partners and The Carlyle Group on the sale of Marle to Dentressangle.
On October 30, Willkie client IK Investment Partners and The Carlyle Group announced that the IK VII Fund has entered into exclusive negotiations with Dentressangle regarding the sale of Marle International, a leading European manufacturer of orthopedic implants.
The transaction remains subject to the information and consultation process of the relevant employee representative bodies in accordance with applicable laws and to the approval of the competent antitrust authorities.
Founded in 1964, Marle has grown to become a leading manufacturer of hip and knee implants and instruments for the orthopedic industry. Marle acts as a strategic partner to medical technology companies worldwide, producing 1.5 million implants annually. The Company operates six production sites in France and Switzerland.
Willkie previously advised IK Investment Partners on the acquisition of Marle in 2016.
The Willkie team included partner Eduardo Fernandez and special European counsel Jeffrey Fouts.